Optimal timing for use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: questions, answers, and more questions

JAMA. 2007 Feb 14;297(6):636-9. doi: 10.1001/jama.297.6.636.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angina, Unstable / drug therapy*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*

Substances

  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex